Related Tags >> Biotech Venture Capital antibodies Drug Discovery Prostate Cancer

nanotechnology News

Most Popular nanotechnology Story

Emerging Drug Developer: Bind Biosciences

November 29, 2007 — 3:09pm ET | By John Carroll

Bind Biosciences hopes to get big on small tech Somewhere between leaving the top job at Acceleron Pharma and jumping onto the Read more...

nanotechnology Press Releases

U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics in Order to Rapidly Find Solutions for Neurological
ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021:
Research and Markets: Handbook of Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity and Applications
Researchers Develop "Smart" Nanotherapeutics that Deliver Drugs Directly to Pancreas
NanoBusiness Commercialization Association Teams with Center of Innovation for Nanobiotechnology and N.C. Department of

Latest Headlines

Russian agency backs upstart nano-bio with tailored pricing plan
September 12, 2011
Self-assembling DNA used in nanoscale delivery system
June 23, 2010
DNA nanobots can assemble particles, follow instructions
May 13, 2010
GSK unveils $300M vaccines plant; FDA recommends seizure therapy; Abbott licenses nanotech;
January 8, 2009
Nanotech start-up offers 3D picture of a cell
July 11, 2008
Nanotech investment will have payoff
June 13, 2008
Emerging Drug Developer: Bind Biosciences
November 29, 2007
Ablynx plots IPO to advance nanobody pipeline
October 10, 2007
Nanotech is promising, but faces hurdles
September 21, 2007
Venture capitalists bet big on nanotechnology
September 12, 2007
FDA to address nanotechnology standards
July 27, 2007
Korea blueprints $14.3B biotech investment plan
November 15, 2006
ALSO NOTED: Memory suspends trial; FDA rejects Cytomedix claim;and much more...
October 16, 2006
FDA cautioned to better regulate nanomaterials
October 10, 2006
NanoBio gains $30M to develop nanoemulsion
August 7, 2006
Nanosphere pockets $57M in VC
May 15, 2006
SPOTLIGHT: BioSante reports adjuvant success
April 23, 2006
ALSO NOTED: CombiMatrix, Novavax develop vaccine tracking; Chemokine sees positive early results; and much more...
November 8, 2005
ALSO NOTED: Avanir selling $16M in shares; Genaera reports positive prelim data; 5T4 antibody-targeted therapy advances; and mu
October 18, 2005
In Focus: CytImmune preps human trials for new nano-based therapy
September 26, 2005

Paid Research Reports

More Research Reports >>